Vontobel Holding Ltd. Horizon Therapeutics Public LTD CO Transaction History

Vontobel Holding Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$107.32 - $113.5 $97,983 - $103,625	913 Added 15.63%	6,754 $737,000
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $2.19 Million - $3.99 Million	-35,036 Reduced 85.71%	5,841 $664,000
Q3 2022 Nov 04, 2022	BUY	$58.92 - $84.67 $470,594 - $676,259	7,987 Added 24.28%	40,877 $2.53 Million
Q2 2022 Jul 27, 2022	BUY	$79.4 - $116.36 $1.53 Million - $2.24 Million	19,282 Added 141.7%	32,890 $2.71 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $165,407 - $210,176	-1,914 Reduced 12.33%	13,608 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $209,932 - $255,408	2,130 Added 15.91%	15,522 $1.68 Million
Q3 2021 Oct 29, 2021	BUY	$91.91 - $110.37 $227,752 - $273,496	2,478 Added 22.7%	13,392 $1.47 Million
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $941,223 - $1.05 Million	10,914 New	10,914 $1.04 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.